We showed that inactivation of Aldh1a1 by its inhibitor or CRISPR (Clustered Regularly-Interspaced Panlindromic Repeat) gene editing can block TAZ-induced lung tumorigenic and CSC phenotypes in vitro and tumor formation in vivo (Figures 8 and 9) . The gene discussed is ALDH1A1; the disease is neoplasm.